Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Insurers push back on Medicare and Medicaid coverage for GLP-1s
Axios
Thursday, February 20, 2025 - 11:37am
tags:
insurers, Medicare, Medicaid, obesity, Novo Nordisk, Eli Lilly, Mounjaro, Wegovy
Lilly’s former M&A chief scours the landscape for potential deals as Immunocore’s new CFO
Pharma Voice
Thursday, February 20, 2025 - 11:35am
tags:
Immunocore, Travis Coy, Eli Lilly, M&A
BridgeBio’s heart drug launch gets off to a fast start
BioPharma Dive
Thursday, February 20, 2025 - 11:34am
tags:
BridgeBio, Attruby, Pfizer, tafamidis, transthyretin amyloidosis cardiomyopathy
Pharma and medtech industry reacts to FDA, CDC and NIH job cuts
Clinical Trials Arena
Thursday, February 20, 2025 - 11:33am
tags:
layoffs, FDA, CDC, NIH, DOGE
Boehringer eyes third quarter FDA verdict for oral HER2 drug
Pharmaphorum
Thursday, February 20, 2025 - 11:29am
tags:
Boehringer Ingelheim, zongertinib, FDA, metastatic non-small cell lung cancer
SMA treatment with Evrysdi 'could start prenatally'
Pharmaphorum
Thursday, February 20, 2025 - 11:27am
tags:
Roche, Evrysdi, SMA
Hims & Hers to offer at-home blood draws and lab testing with new acquisition
CNBC
Thursday, February 20, 2025 - 11:25am
tags:
Hims & Hers Health, M&A, Trybe Labs, diagnostics, Medtech
Novartis, Roche grant CEO pay raises for 2024 as sales grew at the Swiss pharma giants
Fierce Pharma
Wednesday, February 19, 2025 - 9:52pm
tags:
Novartis, Roche, Vas Narasimhan, Thomas Schinecker, executive pay
Recursion CEO launches pre-seed fund in response to NIH cuts
BioPharma Dive
Wednesday, February 19, 2025 - 9:51pm
tags:
Recursion, Altitude Labs, R&D, funding, NIH, Chris Gibson
FTC retains stricter merger guidelines under Trump
BioPharma Dive
Wednesday, February 19, 2025 - 9:49pm
tags:
FTC, M&A, Donald Trump
Ascletis' swift surge into obesity continues with competitive oral GLP-1 data
Fierce Biotech
Wednesday, February 19, 2025 - 9:47pm
tags:
Ascletis Pharma, obesity, clinical trials, ASC30
Trump to meet pharma leaders as they seek drug policy changes
Investing.com
Wednesday, February 19, 2025 - 9:44pm
tags:
Donald Trump, Pharma CEPs
Canada purchases 500,000 doses of GSK's vaccine for bird flu
MSN/Reuters
Wednesday, February 19, 2025 - 9:43pm
tags:
Canada, vaccines, GSK, bird flu, H5N1
Trump set to break WTO rules with potential pharma tariffs
ING
Wednesday, February 19, 2025 - 11:02am
tags:
tariffs, drug importation, Donald Trump
Allay doses first subject in trial of ATX101 for post-surgical pain relief
Clinical Trials Arena
Wednesday, February 19, 2025 - 10:50am
tags:
Allay Therapeutics, ATX101, clinical trials, post-surgical pain
FDA staff handling drug safety for pets and livestock lost jobs in Trump firings
NPR
Wednesday, February 19, 2025 - 10:47am
tags:
FDA, regulatory, Donald Trump, animal health
Stock stagnation prompts a 16% pay cut for AstraZeneca CEO Pascal Soriot despite strong sales sheet
Fierce Pharma
Wednesday, February 19, 2025 - 10:42am
tags:
AstraZeneca, Pascal Soriot, executive compensation, Pharma CEOs
Exelixis Looks to Next-Gen Cancer Drug as Cabometyx Underwhelms Again
BioSpace
Wednesday, February 19, 2025 - 9:56am
tags:
Exelixis, Cabometyx, colorectal cancer, renal cell carcinoma, kidney cancer
Merck pens $300M-per-product collab with Epitopea to locate 'hidden' tumor antigens
Fierce Biotech
Wednesday, February 19, 2025 - 9:54am
tags:
Merck, Epitopea, immunotherapy, biobucks
‘Nothing … off limits’: Kennedy lays out plan for HHS
Politico
Wednesday, February 19, 2025 - 9:46am
tags:
Robert F Kennedy Jr., HHS, Donald Trump, vaccines

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.